Transcriptomics

Dataset Information

7

SNP arrays in matched diagnosis/remission samples of normal karyotype-acute myeloid leukemia


ABSTRACT: We analysed, by last-generation high-resolution SNP arrays, Normal Karyotype (NK)-AML patients at diagnosis (Dx) and remission (R) phases, in order to determine the number of tumor-associated copy number abnormalities (CNAs) and copy neutral-loss of heterozygosity (CN-LOH) regions per patient and to identify possible recurring genomic abnormalities. The number of tumor-associated CNAs was detemined after comparison of 11 matched Dx/R samples using stringent conditions able to reduce the number of false positive CNAs. 8 additional unmatched Dx samples were included in the analysis of recurring CNAs and for detection of broad CN-LOH segments. With the exception of a single outlier case, a low number of CNAs per patient was detected (median value of 1 somatic loss or gain per patient). However, a high prevalence of CNAs (60-70% of the patients showed at least 1 tumor-associated gain or loss) and few recurring CNAs were observed, thus providing new hints towards identification of cooperating mutations. An extensive search of all CN-LOH regions > 1 Mb revealed only 3 broad regions (terminal 12Mb of 22q, terminal 27Mb of 1p and the whole chromosome 21) in three patients out of 19 (16%). CN-LOH of the whole chromosome 21 was responsible for homozygosity of a missense mutation (R80C) of RUNX1/AML1. Our study suggests that a relative submicroscopic copy number stability NK-AML genomes is associated with low recurrence of specific CNAs and CN-LOH in NK-AML patient population. Nineteen AML bone marrow samples were collected at the time of diagnosis (>90% blasts), defined as karyotypically-normal on the basis of standard metaphase cytogenetics (MC) and analysed by the Affymetrix SNP 6.0 arrays. In 11 of such cases (matched Dx) we obtained a bone marrow sample at the remission phase (matched R) of comparable high quality as evaluated by Contrast QC and MAPD values. In 8 cases (unmatched Dx) the corresponding R sample was not available or was not of comparable quality. As a reference set the publicly available data from 270 HapMap individuals were used.

ORGANISM(S): Homo sapiens  

SUBMITTER: Vincenza Barresi   Daniele F Condorelli 

PROVIDER: E-GEOD-21780 | ArrayExpress | 2010-12-31

SECONDARY ACCESSION(S): GSE21780PRJNA127305

REPOSITORIES: GEO, ArrayExpress

altmetric image

Publications

Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes.

Barresi Vincenza V   Romano Alessandra A   Musso Nicolò N   Capizzi Carmela C   Consoli Carla C   Martelli Maria Paola MP   Palumbo Giuseppe G   Di Raimondo Francesco F   Condorelli Daniele F DF  

Genes, chromosomes & cancer 20101101 11


We analyzed, by the latest high-resolution SNP arrays, 19 Normal Karyotype (NK)-AML patients at diagnosis (Dx) and remission (R) phases, to determine the number of tumor-associated copy number abnormalities (CNAs) and copy neutral-loss of heterozygosity (CN-LOH) regions per patient and to identify possible recurring genomic abnormalities. The number of tumor-associated CNAs was determined after comparison of matched Dx/R samples using stringent conditions able to reduce the number of false posit  ...[more]

Similar Datasets

2010-12-31 | GSE21780 | GEO
| GSE76014 | GEO
2014-05-22 | E-GEOD-46745 | ArrayExpress
| GSE71389 | GEO
| GSE71386 | GEO
2009-12-01 | GSE19101 | GEO
2008-12-10 | GSE13557 | GEO
2009-11-23 | GSE16406 | GEO
2008-12-10 | E-GEOD-13557 | ArrayExpress
2011-12-16 | GSE30442 | GEO